<DOC>
	<DOC>NCT00738972</DOC>
	<brief_summary>Evaluate pleiotropic effects of simvastatin in hypertensive patients.</brief_summary>
	<brief_title>Left Ventricular Hypertrophy Reduction With Statins in Hypertensives Patients (MK0653A-168)</brief_title>
	<detailed_description />
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Hypertrophy, Left Ventricular</mesh_term>
	<mesh_term>Pravastatin</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Females Or Males Over 18 Years Old Patients With Systemic Arterial Hypertension Grade I And II According With The European Society Of Cardiology Left Ventricular hypertrophy Demonstrated By Echocardiography Mild To Moderated hypercholesterolemia Willing To Participate And Sign The Informed Consent Form (ICF) Type 1 Or 2 Diabetes Mellitus Familiar hypercholesterolemia Low Density LipoproteinCholesterol (LDLC) &gt; 190 mg/dl History Of Myocardial Infarction Or Stable Chronic Angina Triglycerides &gt;250 mg/dl</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>